Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial by Davis, Kara L, DO, Fox, Elizabeth, MD, Merchant, Melinda S, MD, Reid, Joel M, PhD, Kudgus, Rachel A, PhD, Liu, Xiaowei, PhD, Minard, Charles G, PhD, Voss, Stephan, MD, Berg, Stacey L, Prof, Weigel, Brenda J, Prof, Mackall, Crystal L, Prof

Get full text

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial by Lee, Daniel W, MD, Kochenderfer, James N, MD, Stetler-Stevenson, Maryalice, MD, Cui, Yongzhi K, MD, Delbrook, Cindy, RN, Feldman, Steven A, PhD, Fry, Terry J, MD, Orentas, Rimas, PhD, Sabatino, Marianna, MD, Shah, Nirali N, MD, Steinberg, Seth M, PhD, Stroncek, Dave, MD, Tschernia, Nick, BS, Yuan, Constance, MD, Zhang, Hua, PhD, Zhang, Ling, PhD, Rosenberg, Steven A, Prof, Wayne, Alan S, Prof, Mackall, Crystal L, Dr

Get full text